BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8793243)

  • 1. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG; Mezzano SA
    Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric arterial thrombosis complicating the nephrotic syndrome.
    McGregor DO; Bailey RR
    N Z Med J; 1997 Feb; 110(1038):62-3. PubMed ID: 9076292
    [No Abstract]   [Full Text] [Related]  

  • 6. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M; Grcevska L; Dzikova S
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy--still a treatment dilemma.
    Cameron JS
    N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Membranous nephropathy and crescentic glomerulonephritis].
    Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
    Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C
    J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR
    N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
    Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
    Wetzels JF; Reichert LJ
    Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
    Johnston PA; Goode NP; Aparicio SR; Davison AM
    Transplantation; 1993 Jan; 55(1):214-6. PubMed ID: 8420053
    [No Abstract]   [Full Text] [Related]  

  • 18. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P
    Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
    Moroni G; Faricciotti A; Cappelletti M; Ponticelli C
    Nephrol Dial Transplant; 1999 May; 14(5):1303-5. PubMed ID: 10344388
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ
    Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.